Combination treatment of an IDH1 inhibitor with chemotherapy in IDH1 mutant acute myeloid leukemia

Ann Hematol. 2020 Jun;99(6):1415-1417. doi: 10.1007/s00277-020-04001-w. Epub 2020 Apr 15.
No abstract available

Publication types

  • Letter

MeSH terms

  • Animals
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Consolidation Chemotherapy
  • Disease Models, Animal
  • Humans
  • Induction Chemotherapy
  • Isocitrate Dehydrogenase / antagonists & inhibitors*
  • Isocitrate Dehydrogenase / genetics*
  • Leukemia, Myeloid, Acute / diagnosis
  • Leukemia, Myeloid, Acute / drug therapy*
  • Leukemia, Myeloid, Acute / genetics*
  • Mice
  • Mutation*
  • Treatment Outcome

Substances

  • Isocitrate Dehydrogenase
  • IDH1 protein, human